openPR Logo
Press release

Global Prefilled Syringes Market Growth Augmented By Rise In Prevalence Of Chronic Diseases With Key Companies : Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, Schott Ag, West Pharmaceuticals, Vetter International

10-08-2018 11:15 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Prefilled-Syringes-Market

Prefilled-Syringes-Market

Prefilled syringes are ready to use pharmaceutical products used to deliver parenteral medications. These are mainly used for treatment of chronic conditions that require long-term and self-administration of medication. Prefilled syringes are the ideal choice for single-dose drugs, offering easy-to-use fixed dosage options, thereby helping pharmaceutical companies control costs by minimizing drug overfill, minimize microbial contamination and reduce dosing errors. Prefilled syringes make injections easier and safer for both doctors and patients, with the patient always receives the right amount of dosage without complications.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/162

The prefilled syringes market is expected to gain steady traction in the foreseeable future, with the success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth. For instance, Safelia auto injector developed by Nemera in 2017 won the ‘Patient Centricity & Customization’ innovation award at Pharmapack. Safelia is an innovative auto injector for prefilled syringes, available in variable sizes, suitable for large volume and high viscosity delivery through thinner needles.

"Market Dynamics"

Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for the biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, availability of alternative systems such as nanopatches, microneedles, connected delivery devices, limited shelf life and stability issues of the drugs are the factors restraining the market growth.

Prefilled syringes can be used to administer drugs in treatment of chronic diseases and can also be used for the vaccination purpose, catering to patients suffering from infectious diseases or certain epidemic diseases. Convenience and safety for both the patients and medical professionals offered through these devices are also a major cause leading to growth of the global prefilled syringes market. According to World Health Organization, approximately 2 million healthcare professionals suffer from infectious diseases as result of needle-stick injury. The retractable nature of these prefilled syringes helps to overcome this problem acting as an ideal device to reduce the occurrence of needle-stick injuries. Thus, all of these factors in integration creates highly lucrative growth opportunities for players in the global prefilled syringes market

"Competitive Analysis"

Key companies covered as a part of this study include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group and Terumo Corporation.

Speak to Analyst Before Purchasing This Report: https://www.coherentmarketinsights.com/insight/talk-to-analyst/162

Detailed Segmentation:

Global Prefilled Syringes Market, By Drug Type:
Biologics
Monoclonal Antibodies
Blood Products
Others

Vaccines
Conjugated Vaccines
Live Attenuated Vaccines
Recombinant vaccines
Others

Insulin
Others

Global Prefilled Syringes Market, By Material:
Glass
Plastic & Polymer

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Prefilled Syringes Market Growth Augmented By Rise In Prevalence Of Chronic Diseases With Key Companies : Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, Schott Ag, West Pharmaceuticals, Vetter International here

News-ID: 1286476 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Prefilled

Global Prefilled Syringes Market by Material (Glass Prefilled Syringes, and Plas …
The global prefilled syringes market size is anticipated to reach USD 10.5 billion by 2028, at a CAGR of 8.5% during the forecast period due to the high prevalence of chronic diseases and the rising adoption of self-injection devices. Global prefilled syringes market estimated to grow with a CAGR of 8.5% during the forecast period, 2021-2028. It is owing to the benefits of prefilled syringes such as the low risk of
Benefits of Prefilled Syringes over Traditional Vials and Syringes Driving Prefi …
In 2017, the global prefilled syringes market reached $4.7 billion and is projected to register an 8.3% CAGR during the forecast period (2018-2023). The market is growing because of the extensive pipeline of injectable drugs, rising demand for injectable pharmaceutical products, expanding pharmaceutical industry, increasing prevalence of chronic and lifestyle associated diseases, surging requirement for point-of-care administration, benefits of prefilled syringes over conventional vial and syringe packaging systems, regulations associated
07-23-2019 | Health & Medicine
Factmr
Prefilled Syringes Market - Increasing Use of Glass Prefilled Syringes to Aid th …
With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years. For more incisive insights, Request a Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=603 According to Fact.MR analysis on prefilled syringes,
Development Of Technologically Advanced Prefilled Syringes Is Expected To Boost …
Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syringes are alternatives to other dosage forms such as tablets and capsules. Empty glass or plastic and polymer syringes are filled with the solution of the active pharmaceutical ingredients. Drugs belonging to categories such as cardiovascular, analgesics, neurology, and adjuvants are offered in prefilled syringe delivery systems. Small molecule prefilled
Prefilled Syringe Market Report 2018: Segmentation by Product (Glass Prefilled S …
Global Prefilled Syringe market research report provides company profile for Ompi(IT), Baxter BioPharma Solution(US), ROVI CM(ES), Terumo(JP), Vetter(DE), BD(US), Gerresheimer(DE), Nipro Corporation(JP), Schott forma vitrum(DE) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
Prefilled Syringes Market
Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one